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Abstract
Mass spectrometry-based proteomics, the large-scale analysis of proteins by mass spec‐
trometry, has emerged as a powerful technology over the past decade and has become an
indispensable tool in many biomedical laboratories. Many strategies for differential pro‐
teomics have been developed in recent years, which involve either the incorporation of
heavy stable isotopes or are based on label-free comparisons and their statistical assess‐
ment, and each of these has specific strengths and limitations. This chapter gives an over‐
view of the current state-of-the-art in quantitative or differential proteomics and will be
illustrated by several examples.
Keywords: Mass spectrometry, quantitation, SILAC, heavy isotope labelling, chemical
tagging, 18O labelling
1. Introduction
Analysis of the proteome using mass spectrometry has proven to be an indispensable tool in
biomedical research over the past 15 years or so. Originally, because of technical limitations,
only qualitative measurements were performed for the identification of proteins in a sample.
However, the need to put a quantitative label on proteomics analyses became evident rapidly.
For this reason, several different technologies were developed for their use, in combination
with mass spectrometry, to supply researchers with more quantitative data to investigate, e.g.
the dynamics of a particular proteome. In this chapter, a brief overview of quantitative
approaches in mass spectrometry-based proteomics will be given. Current protocols for
quantitative analysis and software solutions for data analysis will be discussed and examples
from the field (including our own laboratory) will be given to illustrate the power of these
methods.
© 2015 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
2. Mass spectrometry-based proteomics
Before the application of mass spectrometry, protein analysis was mostly based on the
purification of single proteins or protein complexes, followed by the performance of experi‐
ments on these purified proteins or complexes. Usually, such biochemical experiments are
quite laborious and mostly reliant on the extent to which the protein can be purified. Although
mass spectrometry as a technique to study small molecules dates back to the beginning of the
20th century, the use of mass spectrometry in peptide and protein analysis is more recent. The
development of both matrix-assisted laser desorption/ionization (MALDI) and electrospray
ionization (ESI) in the 1980s was key to this development, as these techniques allowed the
ionization of biomolecules such as peptides, proteins and nucleotides, which made their
detection by mass spectrometry possible. The 2002 Nobel Prize in Chemistry was awarded to
John B. Fenn and Koichi Tanaka for the development of these ionisation techniques [1]. With
the possibility to analyse biomolecules, in particular peptides and proteins, using mass
spectrometry, the key step towards proteomics was made. Equally important was the advent
of the genomic age, supplying the databases which are instrumental for the analysis and
identification of proteins, as well as the technical advances of both mass spectrometers and the
(bio)informatic infrastructures that are essential for large data handling.
Mass spectrometry in itself is merely a qualitative analytical technique. The biochemical and
biophysical properties of proteins and peptides are quite variable, which leads to large
differences in properties such as ‘sprayability’ and, thus, in resulting ion intensities between
different peptides, even though these may be present in equimolar amounts in the sample. In
order for mass spectrometry to be useful not only for the qualitative analyses but also for the
quantitative analysis, these caveats and problems need to be addressed and solved. Concern‐
ing the different types of mass spectrometers, there are several physical principles to choose
from. While it goes beyond the scope of this chapter to discuss all of these in details, it is quite
useful to be aware of the different possibilities available as these may influence the perform‐
ance of the quantitative analysis. The type of mass spectrometers that are most widely used in
proteomics are (1) time-of-flight (ToF), (2) quadrupole, (3) (Paul) ion trap, (4) FTICR, or (5)
orbitrap [2,3]. In ToF analysis, the velocity of an ion is measured in order to determine the size
of the particle. The quadrupole analyses the movement of an ion through an electric field, while
the Paul ion trap is a type of quadrupole that uses static direct current and radio frequency
oscillating electric fields to trap ions. In an FTICR mass spectrometer, ions are trapped in a
strong magnetic field and the periodic movement of the ions is translated back to m/z ratios.
In an orbitrap, ions are trapped in an orbital motion around a spindle, while the image current
from the trapped ions is detected and converted to a high-resolution mass spectrum using
Fourier transformation (for a review on orbitrap mass spectrometry, see [3]). Current mass
spectrometers are usually hybrid instruments, which combine two or more of the above
mentioned principles for the analysis of peptides and proteins.
Recent Advances in Proteomics Research2
3. Overview of quantitation methods
The first (semi-)quantitative approach to proteomics was achieved using ‘2D difference in gel
electrophoresis’ (2D-DIGE). With this technique, proteins are separated according to size and
charge, and it includes the incorporation of fluorescent labels (CyDye) to allow the comparison
of two conditions versus an internal standard [4,5]. After separation of the proteins, the spots
are analysed using specialised software, measuring the relative fluorescence intensities. Spots
that appear to be differentially regulated can then be excised from the gel and identified using
mass spectrometry [6]. The usage of an internal standard, usually a mix of the two measured
conditions, supplies this method with quantitative properties. However, the limitations of 2D-
DIGE, and of 2D gel electrophoresis for complex samples in particular, have led to decreased
usage of the technique. Because of limitations in the number of samples to be compared, in
studying membrane-bound proteins, as well as in the relative low proteome coverage,
alternative technologies have now superseded the use of 2D-DIGE as a quantitative proteomics
method. Techniques currently used for quantitation are summarized in Figure 1 and discussed
further below.
Figure 1. Overview of the stage in which incorporation of the stable isotope labels occurs using different labelling
methods in quantitative proteomics. The colour of the diamonds represents the two proteins samples which are differ‐
entially labelled and compared in the workflow. (Figure adapted from [7]).
Nowadays, the techniques most frequently used to quantify proteins using mass spectrometry
involve labelling proteins with isotopically labelled tags, which can be distinguished in the
mass spectrometer because they differ in mass. Differential mass tags result in a (usually only
small) mass difference between the ‘light’ and ‘heavy’ sample, while proteins and/or peptide
properties such as the retention time on a chromatography column are not affected. This allows
for the simultaneous analysis of the tagged proteins in a single mass spectrum or LC-MS run.
Several methods based on the addition of labelled tags are used in modern proteomics, each
with their strong and weak points. Furthermore, with the development of more sensitive and
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faster mass spectrometers, methods that allow quantitation of proteins in a label-free manner
have been developed, including spectral counting and the comparison of ion intensities. These
techniques have the distinct advantage of requiring no (chemical) labelling of the sample, but
the trade-off is the lower accuracy of the quantitation. All of these techniques will be described
in this chapter, including several examples of how they are used to answer biomedical
questions currently posed in the field.
4. Metabolic labelling
The use of amino acids with either of light or heavy stable N and/or C isotopes in growth
medium is an approach that was introduced by the Mann lab [8]. Because the labelling takes
place at the very beginning of the proteomics workflow, samples can be mixed at the earliest
possible time point. Consequently, the occurrence of systematic errors that may be introduced
during sample handling is reduced [8,9]. Although this method has shown to be a powerful
way to perform quantitation in proteomics in many different applications, there are also
several disadvantages to using metabolic labelling, most importantly the inability for appli‐
cation in human tissue samples. Because the samples need to be metabolically active in order
to incorporate the label, this automatically precludes, e.g. blood and biopsy samples. This
makes it impossible to use metabolic labelling in a diagnostic setting. Furthermore, for some
metabolic labelling approaches, reliable software for data analysis is still lacking. The labelling
itself is quite time-consuming, as it takes some time for cell cultures to become completely
labelled. Finally, the costs of metabolic labelling approaches may be substantial due to the
amount of expensive labelled reagents [10]. Below, several types of metabolic labelling will be
discussed in more detail.
4.1. 15N labelling
The use of heavy nitrogen (15N) to label whole model organisms dates back to the 1960s, when
it was applied to plants for the first time (see [10] for a review on the matter). In the late 1990s,
this strategy took off for other organisms such as E. coli, yeast and Drosophila [9, 11, 12]. Protein
labelling is usually achieved by adding salts containing labelled nitrogen into the medium (in
the form of, e.g. NH4Cl), which will then be metabolised by the organism and finally incorpo‐
rated into proteins. The advantage of this labelling approach, apart from incorporation at the
earliest possible moment, is that labelling of all peptides is guaranteed. However, it also
provides increased complexity of the sample, most importantly because the mass difference
between the light and the heavy counterpart peptides is basically variable for each peptide
pair. This presents a major challenge for suitable bioinformatics solutions for qualitative and
quantitative data analysis. 15N labelling has successfully been used in the study of prokaryotes,
for instance, the proteome of S. aureus was analysed extensively using 15N labelled growth
medium [13]. By tying the identified proteins to the completely sequenced genome of S.
aureus, 80% of all expressed proteins were identified using this approach. A study by Kohl‐
mann and coworkers [14] displayed the power of 15N labelling in shotgun proteomics in
analysing R. eutropha, a prokaryote that can grow on 13CO2 as the sole carbon source and is
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used for the industrial production of stable isotope-labelled biomolecules. R. eutropha has the
ability to switch to lithoautotrophy, i.e. to switch to a source of reduced minerals to satisfy its
energy needs. By studying the proteome of R. eutropha under both normal and lithoautotrophic
conditions, a large upregulation of specific proteins was observed when the prokaryote had
to switch its energy source, including chemotaxis-related proteins [14,15].
4.2. 13C labelling
Another prime candidate for metabolic labelling is 13C, as carbon is a key player in protein
chemistry. 13C labelling has been successfully used in the determination of protein turnover
rates. For instance, by feeding E. coli on 13C-labelled glucose, protein turnover rates using only
a single culture could be measured by mass spectrometry [16]. Moreover, the method is
applicable to shotgun proteomics, which allows for a broader overview of proteins and their
turnover rates. In order to reduce the costs of metabolic labelling, a technique called ‘subtle
modification of isotope ratio proteomics’ (SMIRP) was developed [17]. In SMIRP, an increase
of only ~1% in isotope ratio can be used to relatively quantify proteins by calculating the ratio
of isotopes and comparing it to the variability occurring in nature.
4.3. SILAC
In cultured cells, the metabolic labelling method of choice is stable isotope labelling using
amino acids in culture (SILAC), which uses isotopically labelled amino acids (See Figure 2 for
a typical SILAC workflow). In order for the amino acids to be incorporated into proteins, it is
necessary to determine whether the studied organism is an auxotroph for said amino acid. If
a cell or organism is an auxotroph for an amino acid, it cannot synthesize this amino acid itself
and, therefore, the amino acid should be supplied in the food or in the growth medium [8].
Usually in SILAC, labelled lysine and arginine are used, which are particularly useful for
proteins that are processed with trypsin. Since trypsin cleaves after lysine and arginine, in
principle all peptides except for the C-terminal peptide are labelled. If the cells are auxotroph
for the selected amino acids, all proteins in a cells are generally completely labelled after several
doublings [8]. Conversely, this means that the cells must be dividing, which precludes the use
of this technique on primary tissue samples. A complication that has been described in the
literature that could potentially interfere with quantitation of SILAC labelled proteins is the
natural occurrence of arginine-to-proline conversion. While lysine and arginine are relatively
stable in the cell, it is possible for the cell to produce proline from spare arginine, which can
then lead to heavy labelled proline. Obviously, this is undesirable and should be accounted
for either experimentally or during data analysis (see e.g. [18]).
Labelling using SILAC can also be used to examine post-translational protein modifications
such as phosphorylation and ubiquitination in a quantitative manner. An example of this is a
phosphoproteomic study in yeast after the knockout of a kinase that plays a role in growth
and division [19]. SILAC can in principle be used for any cultured cell type. A recent study
from our lab into hormonal signalling in Drosophila combined SILAC mass spectrometry with
transcriptome analysis [20]. Drosophila Kc cells were stimulated with the key insect hormone
ecdysone and both mRNA expression and protein expression were studied during a time
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course. The results showed a correlation in the changing levels of mRNA and protein over
time, although it became evident that in general there is a time delay between mRNA and
protein expression. Not all mRNA–protein pairs showed this delay though, which could be
attributed to post-transcriptional regulation events of mRNAs and to variable stability of
proteins. Several interesting proteins linked to signalling pathways such as target of rapamycin
(TOR) and Notch were identified as being regulated by ecdysone signalling, giving an
indication of the scope of the ecdysone system. This study shows the applicability of SILAC
in studies where a significant number of proteins are changed, and the correlation between
mRNA and protein levels show the quantitative power of SILAC technology, as well as the
power of this method to identify signalling networks in cellular systems. In general, there is
Figure 2. Typical SILAC workflow: cells representing two different biological conditions are grown in either light or
heavy medium containing amino acid with stable heavy isotopes. Cells are then harvested and mixed in equal
amounts and all sample preparation is performed on the mixed cell populations. In the final mass spectrum, a tryptic
peptide will be observed as a peak pair, which represents the two sample conditions. By calculating the peak intensity
ratio, the conditions can be compared in a quantitative fashion.
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also a correlation, albeit weak, between steady-state levels of mRNA and protein (Figure 3).
This is mainly true for products that show relatively high expression, which has also been
reported in other studies. From this plot, it becomes also clear that for many mRNA products
no corresponding protein was identified, illustrating the technical limitations in proteomics
that still prevent very low abundant proteins to be detected. In addition, there were several
protein products that could not be matched to mRNAs, indicating that, since the intensities of
these proteins are generally similar to those with a matched mRNA, this could be attributed
to the incomplete annotation of the Drosophila database.
Figure 3. A scatter plot of absolute protein intensities (based on iBAQ values) versus absolute mRNA intensities (based
on FPKM values) shows that steady-state levels of protein and mRNA show a weak correlation (R2= 0.366). The intensi‐
ty distribution of proteins for which no corresponding hit in the transcriptome analysis was found is represented by
the green box plot. This distribution is very similar to the distribution of overlapping hits (blue data points).
An interesting technological progression in the recent years has been the emergence of fully
labelled SILAC organisms, such as fruit flies, mice and rats, which allows for in vivo quanti‐
tative protein analysis [12,21,22]. This allows scientists to study alterations of protein levels in
lab mice with as little variation possible, which in turn makes it possible to study the dynamic
proteome in tissue. Currently, the generation of SILAC labelled mice is limited by cost
considerations due to the expenses required to raise the mice on a diet of labelled food and
this has prevented large-scale usage thus far.
Finally, the so called ‘super-SILAC’ standard is a pool of multiple cell lines that have been
labelled using SILAC, which is then spiked into experimental samples. By spiking all the
samples with this standard, quantitation becomes possible without the necessity to label the
samples themselves using SILAC. This allows the application of SILAC quantitation in patient
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tissue, which can evidently not be labelled using traditional SILAC. It should be noted that it
is recommended to have a representative sample for the tissue to be studied in the SILAC
standard, which limits the usage of this technique to tissues with a representative cell line. For
a more in-depth review on this topic, see [23].
5. Chemical labelling strategies
The use of chemical labelling strategies for relative quantitation in proteomics dates back to
the late 1990s [24]. The major advantages of using chemical techniques rather than metabolic
labelling are the reduced cost and the higher speed of sample processing and analysis. Where
labelling cells with SILAC may take up to several days [8], chemical labelling protocols are
usually performed in less than an hour [25]. Chemical labelling can be applied to any protein
sample, not just metabolically active samples, and some of the techniques allow for a high
number of samples to be analysed simultaneously [26]. However, since chemical labelling is
done either at the protein level or at the peptide level and at a relatively late stage in the sample
preparation protocol, systematic errors are introduced more readily. Also, labelling at the
protein level requires specific proteins such as cysteine or lysine, which makes peptides
without these amino acids not quantifiable [10,24].
5.1. Labelling with an Isotope-Coded Affinity Tag (ICAT)
The first chemical labelling technique that was described for quantitative mass spectrome‐
try was the isotope-coded affinity tag (ICAT). In ICAT, a thiol reactive group is used to
conjugate the tag to cysteine residues in the protein. Apart from the reactive group, the tag
has a linker and a biotin moiety. The linker has either eight hydrogen atoms for the light
version or eight deuterium atoms for the heavy version, which are used to distinguish two
differentially labelled conditions by the 8 Da shift in the mass spectrum [26].  The biotin
moiety of the tag can be used to affinity purify the tagged peptides after trypsinisation.
The weakness of  ICAT lies  in the requirement of  cysteine residues to be present  in the
peptide, which leads to a limitation in the amount of peptides tagged. Furthermore, the
presence of deuterium causes a shift in elution times when peptides are fractionated using
HPLC, which hampers subsequent data analysis [27]. This elution time shift problem was
later solved by introducing 13C instead of D into the linker moiety. ICAT labelling has, for
instance, been used to investigate the redox state of proteins in a study to the formation of
reactive oxygen species and the way this is dealt with by the cell [28]. The ability to use
ICAT in human samples has been exploited in screening cerebrospinal  fluid samples of
Alzheimer patients to find novel prognostic biomarkers [29].
5.2. ICPL
Labelling using isotope-coded protein labels (ICPL) is based on a similar principle as ICAT. In
ICPL, lysine residues in intact proteins are labelled, which are more common than cysteine
residues. The mass difference between isotope pairs of the labelled and unlabelled peptides
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depends on the amount of labelled lysine residues in the peptide and can be determined fairly
simply, which provides strong constraints for database searches [30]. A disadvantage of
labelling lysine residues is that modifying the residue side chain makes it impossible for trypsin
to cleave at this particular lysine residue. As such, this results in much longer peptides after
trypsin digestion, as cleavage will only occur after arginine residues, which may lead to
proteolytic peptides that cannot be detected. It is therefore recommended to either use another
or an additional protease for protein digestion, or to perform the labelling at the peptide level
after proteolytic cleavage. A study on tumour cell senescence in which ICPL was successfully
used is a good indicator for the power of quantitative proteomics in general. Here, an effect of
tumour cell senescence on several important tumourigenesis proteins such as cMYC and key
metabolic enzymes such as ATP synthetases were found [31].
5.3. Isobaric tagging
Tandem mass tags (TMT) and isobaric tag for relative and absolute quantitation (iTRAQ) are
based on labelling peptides with isobaric tags. Here, the label is conjugated to the N-termini
and lysine residues of peptides, so that in principle every peptide is labelled (Figure 4). The
various isobaric tags themselves have different masses, but are balanced by a linker moiety
that ensures identical intact masses for all possible combinations of tag plus linker. As a
consequence, differentially labelled peptides end up in the same precursor peak in the mass
spectrum. Only when this peak is subsequently selected for fragmentation, the linkers will be
cleaved first, which leads to the appearance of peaks corresponding to the different tags
(‘reporter ions’) in the low m/z region of the spectrum. The relative peak intensities of the tags
are then used for quantitation [26]. Since identical peptides end up in the same peak, the
complexity of the MS spectrum is not altered as a result of the labelling procedure. Further‐
more, there are commercial kits available with up to 10 different tags, providing the possibility
to run and compare 10 samples simultaneously. The most prominent disadvantage of this
method is that the tag, just like most other chemical tags, is incorporated at the peptide level.
Also, due to the low m/z values of the reporter ions, not all mass spectrometer types are suitable
for detection.
Due to the high number of samples that can be measured in one run, its applicability to human
tissue samples and the availability of high-resolution mass spectrometers capable of ion
detection in the low m/z region, isobaric tagging has quickly become a popular method for the
relative quantitation of proteins. For example, by using iTRAQ labelling for quantitation,
differentially regulated phosphorylation sites could be detected that were phosphorylated by
ATM/ATR, which are highly conserved kinases key in DNA damage repair [32]. iTRAQ
labelling has recently been used to compare the proteome profiles of healthy brains to several
prion diseased brains such as Creutzfeldt–Jakob disease [33]. This study showed that the
changes in protein expression of different prion diseases are markedly similar, while most
changes at the protein level were found in the cerebellum. This study provides an excellent
example of biomarker research using mass spectrometry and could be a step towards defining
biomarkers for different prion diseases, which are otherwise difficult to classify.
Quantitative Mass Spectrometry-based Proteomics
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5.4. Dimethyl labelling
A simple method of labelling compounds at the peptide level for relative quantitation is
dimethylation. Either light-labelled (with H) or heavy-labelled (with D) dimethyl groups are
conjugated to the N-terminus of the peptides and to free lysine residue side chains. The
advantages of dimethyl labelling include low cost, high speed and possibilities for automated
sample preparation. However, since labelling occurs at the peptide level, variation between
runs is still inherent to the process [10,34]. The first incarnation of dimethyl labelling was
limited to only two different flavours. However, using isotopic isomers (‘isotopomers’) of
formaldehyde with either only D or a combination of 13C and D, up to three different samples
can now be compared in a single run [35] (Figure 5). Although this may still be lower than the
amount of different labels that can be achieved using isobaric tagging, it is significantly
cheaper. Dimethyl labelling can be used for a variety of quantitative measurements, for
instance, after a pulldown or immunoprecipitation enrichment protocol. Using an antibody to
probe for phosphopeptides in combination with labelling allows one to quantitatively monitor
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Figure 4. Principle of isobaric tagging. Peptides are tagged with chemical labels that have identical masses due to a
delicate balance between individual tag and linker masses. Labelled peptides are then mixed and measured by mass
spectrometry. In the mass spectrum, labelled peptides will appear as one peak, but only when these peptides are se‐
lected and fragmented by MS/MS, the mass tags will be released from the linker and will show up in the mass spec‐
trum as differential reporter ions in the low m/z region. This allows for the relative abundance determination.
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phosphorylation events [36]. Another possibility that was recently introduced is using
dimethylation to study DNA–protein interactions, e.g. by using an oligonucleotide to pull
down the proteins and performing the dimethylation labelling on the proteins enriched for
[37]. These widely different applications show the power of dimethylation as a quantitative
proteomics tool.
Figure 5. Labelling schemes of triplex stable isotope dimethyl labelling. R = remainder of the peptide. Figure adapted
from [35].
5.5. 18O labelling
Another way to differentially label samples for quantitative purposes is the use of heavy
oxygen. This labelling method is different from other labelling protocols in that the label
incorporation is achieved during the digestion of proteins into peptides. By performing the
digestion in water that contains 18O instead of 16O, the carboxyl terminus of every peptide will
incorporate two 18O atoms. This method can be incredibly fast, with reports of labelling being
achieved in 15 min [25]. A potential pitfall is that the labelling may be incomplete when not
performed in a correct manner, leading to multiple peaks in the MS spectrum and therefore
resulting into difficulties in quantitation [25,38]. Our lab has described a protocol to avoid
incomplete labelling and to assure full incorporation of the heavy oxygen label [39]. By using
immobilized trypsin under acidic conditions, all proteolytic peptides could be fully labelled
with heavy oxygen with no traces of back-exchange. The labelling protocol was implemented
into a protein–protein interaction analysis pipeline to differentiate between bona fide interaction
partners of the low-level expressing cell cycle regulator cyclin-dependent kinase 9 (Cdk9) and
non-specifically binding or background proteins (Figure 6). Previously known, as well as
novel, interaction partners of Cdk9 were characterized, among which most notable are the
Mediator complex and several other proteins involved in transcriptional regulation. It was
Quantitative Mass Spectrometry-based Proteomics
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shown that a differential proteomics approach based on 18O labelling provides a valuable
method for high-confidence determination of protein interaction partners and is easily
implemented in protein network analysis workflows.
Figure 6. Example MS spectra of tryptic peptides from a 1:1 mixture of a Cdk9 co-IP experiment (light) and a control IP
sample (heavy). (A) The tryptic peptide LGTPELSPTER, which originates from the contaminant acetyl-CoA carboxy‐
lase shows both the light and heavy forms of the peptide, and as such, is a non-specific protein. (B) The peptide
GPPEETGAAVFDHPAK, of cyclin T1, can only be detected in the light sample and is therefore an interactor with
Cdk9 [39].
Another method to achieve consistent labelling is to use alternative proteases besides trypsin,
e.g. β-lactamase [40], which eliminates the incorporation of two heavy oxygen atoms and limits
it to one atom consistently.
6. Absolute Quantitation (AQUA)
All label-based approaches described above are geared towards generating relative quantita‐
tive measurements. In many cases though, it would be interesting to measure absolute
quantities of proteins instead. In order to gain absolute quantitation results, synthesized
peptides or proteins containing heavy isotope labels that correspond to the target peptide or
protein of interest can be spiked into the sample at a known concentration, after which the
intensities of target and standard can be compared to one another. Obviously, the standard
peptide can be modified with one or multiple post-translational modifications if needed [41].
Due to the fact that this spiked standard provides absolute rather than relative quantitation,
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this technique has been dubbed absolute quantitation (AQUA). Spike-in components that can
be used for AQUA include peptides with stable isotopes incorporated into one or several amino
acids [41], a construct in which several peptides are strung together (which has the added
advantage of being able to quantify multiple peptides in one run [42]), or an entirely labelled
protein to quantify the amount of protein [43]. As with other quantitation techniques, the stage
at which the label is incorporated largely determines the extent of the systematic quantitation
error that is introduced into the sample. In studying hormonal influence on blood pressure,
and more specifically angiotensin II, spiking in the synthesized heavy labelled angiotensin has
been used to absolutely quantify protein levels in plasma. As such, it was shown that chronic
kidney disease patients had strongly increased levels of angiotensin II [44]. These results show
that AQUA can be useful in the field of biomarker research, although it has many more
applications, such as in assessing the levels of enzymes in prokaryotes [45].
7. Label-free quantitation
With the development of better and faster mass spectrometers with higher sensitivity and
heavier duty cycles, the number of studies that use label-free quantitation (LFQ) methods has
increased over the past few years. The obvious advantage of LFQ is that no sample processing
other than the standard LC-MS procedures is needed. Furthermore, there is no need for often
expensive labelling kits. There are two major approaches employed in label-free quantitation:
spectral counting and intensity-based quantitation. Quantitation by spectral counting is based
on the observation that peptides that are more abundant will be detected and fragmented more
often by the mass spectrometer, and as such the MS/MS count gives information about the
abundance of the protein. However, there are several issues that should be taken into account
here. In general, larger proteins generate more proteolytic peptides, which increases the chance
that multiple peptides for one such protein are detected. Furthermore, in principle every
peptide has different physicochemical properties, which influence the ionizability and,
therefore, the detectability in the mass spectrometer. To address this, several modifications of
spectral counting have been developed, which incorporate mathematical corrections, such as
introducing a normalised spectral abundance factor into the equation to account for protein
length variability (e.g. emPAI [46]). In intensity-based quantitation, on the other hand, the
quantitation is based on the total amount of peptide that is detected in a specific retention time
window for which the area under the curve in the chromatogram is accurately determined
(extracted ion currents (or XICs) of peptides). LFQ has benefited greatly from recent develop‐
ments in mass spectrometer hardware as it increases the number of quantifiable features
present in a given LC-MS run and allows averaging over more peptides for protein quantita‐
tion [47]. In order for the ion intensity quantitation to be reproducible, normalization steps are
required as differences in the total amount of protein loaded onto the LC-MS system and
instrument variances need to be accounted for. Because of this, powerful software is required
and has been developed to perform this type of peptide and protein quantitation (see [48] for
an in-depth review). An interesting label-free quantitation technique has been described that
combines peptide counting, spectral counting and ion intensities into the so-called normalized
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spectral index [49]. Using this method, the variance between multiple LC-MS runs was largely
eliminated. This method shows great promise in achieving reproducible label-free quantita‐
tion.
8. Software applications for quantitative mass spectrometry
Quantitative proteomic data are typically very complex and the data analysis requires
specialized software. The main challenge concerns incomplete data, as even modern advanced
mass spectrometers cannot sample and fragment every peptide ion present in a complex
sample. As a consequence, only a subset of peptides and proteins present in a sample can be
identified. Over the past years, several strategies for mass spectrometry-based quantitative
proteomics and corresponding computational methodology for the processing of quantitative
data sets have been developed (reviewed in ([50,51]), as different quantitative LC-MS methods
require different software solutions for data analysis. Quantitation can be achieved by
comparing peak intensities in differential stable isotopic labelling, via spectral counting, or by
using the ion current in label-free LC-MS measurements. Many software solutions have been
published and can be used freely, with specific instrument compatibility and processing
functionality which can deal with these basically different quantitation methods. The re‐
searcher has to choose the appropriate software solution for his quantitative proteomic
experiments based on the experimental and analytical requirements. Since it goes beyond the
scope of this chapter to discuss all of the available software tools separately, we refer the reader
to an extensive and up-to-date overview of software solutions including links to websites for
downloads at http://www.ms-utils.org.
9. Concluding remarks
In summary, all of the mass spectrometry-based quantitation methods have their particular
strengths and weaknesses and the researcher has to choose the best method from the multitude
of methods that have emerged for the analysis of simple and complex (sub-) proteomes using
quantitative mass spectrometry for his specific research. This choice depends on the availa‐
bility of high-resolution mass spectrometer and LC equipment, the available expertise present
in the lab and the financial aspects involved. Quantitative proteomics methods have become
mature and can now be applied at a large scale to the study of proteomes and their dynamics.
Using the labelling methods described in this chapter, thousands of proteins can be identified
and quantified in a single experiment. However, there is still room for improvements to both
the experimental strategies for the quantitative analysis of very complex mixtures and of their
post-translational modifications and to appropriate bioinformatics and statistical approaches
in order to obtain meaningful interpretations of the results. The ultimate goal is to generate
quantitative proteomic data at a scale that would allow the comprehensive investigation of a
biological phenomenon.
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